Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Alon, US
   Preservation of bone mass in pediatric dialysis and transplant patients
   ADVANCES IN RENAL REPLACEMENT THERAPY
   
   U.S. Alon, "Preservation of bone mass in pediatric dialysis and transplant patients", ADV RENAL R, 8(3), 2001, pp. 191-205
2. Sakhaee, K
   Is there an optimal parathyroid hormone level in end-stage renal failure: the lower the better?
   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
   
   K. Sakhaee, "Is there an optimal parathyroid hormone level in end-stage renal failure: the lower the better?", CURR OP NEP, 10(3), 2001, pp. 421-427
3. Fried, L; Prichard, S; Piraino, B; Bleyer, A
   Peritoneal dialysis case forum
   PERITONEAL DIALYSIS INTERNATIONAL
   
   L. Fried et al., "Peritoneal dialysis case forum", PERIT DIA I, 21(4), 2001, pp. 420-427
4. Cannata-Andia, JB
   Reconsidering the importance of long-term low-level aluminum exposure in renal failure patients
   SEMINARS IN DIALYSIS
   
   J.B. Cannata-Andia, "Reconsidering the importance of long-term low-level aluminum exposure in renal failure patients", SEMIN DIAL, 14(1), 2001, pp. 5-7
5. Moe, SM; Zekonis, M; Harezlak, J; Ambrosius, WT; Gassensmith, CM; Murphy, CL; Russell, RR; Batiuk, TD
   A placebo-controlled trial to evaluate immunomodulatory effects of paricalcitol
   AMERICAN JOURNAL OF KIDNEY DISEASES
   
   S.M. Moe et al., "A placebo-controlled trial to evaluate immunomodulatory effects of paricalcitol", AM J KIDNEY, 38(4), 2001, pp. 792-802
6. Lorenzo, V; Martin, M; Rufino, M; Jimenez, A; Malo, AM; Sanchez, E; Hernandez, D; Rodriguez, M; Torres, A
   Protein intake, control of serum phosphorus, and relatively low levels of parathyroid hormone in elderly hemodialysis patients
   AMERICAN JOURNAL OF KIDNEY DISEASES
   
   V. Lorenzo et al., "Protein intake, control of serum phosphorus, and relatively low levels of parathyroid hormone in elderly hemodialysis patients", AM J KIDNEY, 37(6), 2001, pp. 1260-1266
7. Fukagawa, M; Akizawa, T; Kurokawa, K
   Is aplastic osteodystrophy a disease of malnutrition?
   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
   
   M. Fukagawa et al., "Is aplastic osteodystrophy a disease of malnutrition?", CURR OP NEP, 9(4), 2000, pp. 363-367
8. Smans, KA; D'Haese, PC; Van Landeghem, GF; Andries, LJ; Lamberts, LV; Hendy, GN; De Broe, ME
   Transferrin-mediated uptake of aluminium by human parathyroid cells results in reduced parathyroid hormone secretion
   NEPHROLOGY DIALYSIS TRANSPLANTATION
   
   K.A. Smans et al., "Transferrin-mediated uptake of aluminium by human parathyroid cells results in reduced parathyroid hormone secretion", NEPH DIAL T, 15(9), 2000, pp. 1328-1336
9. Billa, V; Zhong, AM; Bargman, J; Vas, S; Wong, PY; Oreopoulos, DG
   High prevalence of hyperparathyroidism among peritoneal dialysis patients:A review of 176 patients
   PERITONEAL DIALYSIS INTERNATIONAL
   
   V. Billa et al., "High prevalence of hyperparathyroidism among peritoneal dialysis patients:A review of 176 patients", PERIT DIA I, 20(3), 2000, pp. 315-321
10. Holgado, R; Haire, H; Ross, D; Sprague, S; Pahl, M; Jara, A; Martin-Malo, A; Rodriguez, M; Almaden, Y; Felsenfeld, AJ
    Effect of a low calcium dialysate on parathyroid hormone secretion in diabetic patients on maintenance hemodialysis
    JOURNAL OF BONE AND MINERAL RESEARCH
    
    R. Holgado et al., "Effect of a low calcium dialysate on parathyroid hormone secretion in diabetic patients on maintenance hemodialysis", J BONE MIN, 15(5), 2000, pp. 927-935
11. Maluche, HH; Monier-Faugere, MC
    Hyperphosphatemia: pharmacologic intervention yesterday, today and tomorrow
    CLINICAL NEPHROLOGY
    
    H.H. Maluche e M.C. Monier-Faugere, "Hyperphosphatemia: pharmacologic intervention yesterday, today and tomorrow", CLIN NEPHR, 54(4), 2000, pp. 309-317
12. Sanchez, MC; Bajo, MA; Selgas, R; Mate, A; Millan, I; Martinez, ME; Lopez-Barea, F
    Parathormone secretion in peritoneal dialysis patients with adynamic bone disease
    AMERICAN JOURNAL OF KIDNEY DISEASES
    
    M.C. Sanchez et al., "Parathormone secretion in peritoneal dialysis patients with adynamic bone disease", AM J KIDNEY, 36(5), 2000, pp. 953-961
13. Ghitu, S; Oprisiu, R; Benamar, L; Said, S; Albu, AT; Arsenescu, I; El Esper, N; Moriniere, P; Fournier, A
    Renal osteodystrophy: Its management in patients on maintenance dialysis
    NEPHROLOGIE
    
    S. Ghitu et al., "Renal osteodystrophy: Its management in patients on maintenance dialysis", NEPHROLOGIE, 21(8), 2000, pp. 413-424
14. Hottelart, C; Bako, G; Oprisiu, R; Georgita, A; Presne, C; Sarraj, A; Moriniere, P; El Esper, N; Fournier, A
    Renal osteodystrophy (2): its treatment before dialysis.
    NEPHROLOGIE
    
    C. Hottelart et al., "Renal osteodystrophy (2): its treatment before dialysis.", NEPHROLOGIE, 21(6), 2000, pp. 275-282
15. Oprisiu, R; Hottelart, C; Ghitsu, S; Said, S; Westeel, PF; Moriniere, P; El Esper, N; Pruna, A; Fournier, A
    Renal osteodystrophy: invasive versus non invasive diagnosis of its pathological varieties
    NEPHROLOGIE
    
    R. Oprisiu et al., "Renal osteodystrophy: invasive versus non invasive diagnosis of its pathological varieties", NEPHROLOGIE, 21(5), 2000, pp. 229-237
16. Perales, MCS; Cortes, MJG; Borrego, FJ; Martinez, SF; Borrego, J; del Barrio, PP; Liebana, A; Banasco, VP
    Long-term hemodialysis with 2.5 mEq/L dialysate calcium concentration in relative hypoparathyroidism: Effects on bone mass
    NEFROLOGIA
    
    M.C.S. Perales et al., "Long-term hemodialysis with 2.5 mEq/L dialysate calcium concentration in relative hypoparathyroidism: Effects on bone mass", NEFROLOGIA, 20(3), 2000, pp. 254-261
17. Slatopolsky, E; Finch, J; Clay, P; Martin, D; Sicard, G; Singer, G; Gao, P; Cantor, T; Dusso, A
    A novel mechanism for skeletal resistance in uremia
    KIDNEY INTERNATIONAL
    
    E. Slatopolsky et al., "A novel mechanism for skeletal resistance in uremia", KIDNEY INT, 58(2), 2000, pp. 753-761
18. Indridason, OS; Quarles, LD
    Comparison of treatments for mild secondary hyperparathyroidism in hemodialysis patients
    KIDNEY INTERNATIONAL
    
    O.S. Indridason e L.D. Quarles, "Comparison of treatments for mild secondary hyperparathyroidism in hemodialysis patients", KIDNEY INT, 57(1), 2000, pp. 282-292
19. Jorgetti, V; Lopez, BD; Caorsi, H; Ferreira, A; Palma, A; Menendez, P; Douthat, W; Olaizola, I; Ribeiro, S; Jarava, C; Moreira, E; Cannata, J
    Different patterns of renal osteodystrophy in Iberoamerica
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES
    
    V. Jorgetti et al., "Different patterns of renal osteodystrophy in Iberoamerica", AM J MED SC, 320(2), 2000, pp. 76-80
20. Navarro, JF; Mora, C; Macia, M; Garcia, J
    Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients
    PERITONEAL DIALYSIS INTERNATIONAL
    
    J.F. Navarro et al., "Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients", PERIT DIA I, 19(5), 1999, pp. 455-461
21. Hampl, H; Steinmuller, T; Frohling, P; Naoum, C; Leder, K; Stabell, U; Schnoy, N; Jehle, PM
    Long-term results of total parathyroidectomy without autotransplantation in patients with and without renal failure - An argument for total parathyroidectomy alone
    MINERAL AND ELECTROLYTE METABOLISM
    
    H. Hampl et al., "Long-term results of total parathyroidectomy without autotransplantation in patients with and without renal failure - An argument for total parathyroidectomy alone", MIN ELECT M, 25(3), 1999, pp. 161-170
22. Malluche, HH; Monier-Faugere, MC
    Understanding and managing hyperphosphatemia in patients with chronic renal disease
    CLINICAL NEPHROLOGY
    
    H.H. Malluche e M.C. Monier-Faugere, "Understanding and managing hyperphosphatemia in patients with chronic renal disease", CLIN NEPHR, 52(5), 1999, pp. 267-277
23. Mawad, HW; Sawaya, BP; Sarin, R; Malluche, HH
    Calcific uremic arteriolopathy in association with low turnover uremic bone disease
    CLINICAL NEPHROLOGY
    
    H.W. Mawad et al., "Calcific uremic arteriolopathy in association with low turnover uremic bone disease", CLIN NEPHR, 52(3), 1999, pp. 160-166
24. Weinreich, T; Zapf, J; Schmidt-Gayk, H; Ritzel, H; Delling, G; Reichel, H
    Insulin-like growth factor 1 and 2 serum concentrations in dialysis patients with secondary hyperparathyroidism and adynamic bone disease
    CLINICAL NEPHROLOGY
    
    T. Weinreich et al., "Insulin-like growth factor 1 and 2 serum concentrations in dialysis patients with secondary hyperparathyroidism and adynamic bone disease", CLIN NEPHR, 51(1), 1999, pp. 27-33
25. Ritzel, H; Delling, G; Schulz, W
    Bone biopsy and clinical findings in patients with renal osteodystrophy
    NIEREN-UND HOCHDRUCKKRANKHEITEN
    
    H. Ritzel et al., "Bone biopsy and clinical findings in patients with renal osteodystrophy", NIEREN HOCH, 28(11), 1999, pp. 417-422
26. Reichel, H; Benzing, C
    Pathogenesis of adynamic bone disease in chronic renal failure
    NIEREN-UND HOCHDRUCKKRANKHEITEN
    
    H. Reichel e C. Benzing, "Pathogenesis of adynamic bone disease in chronic renal failure", NIEREN HOCH, 28(10), 1999, pp. 379-385
27. Fournier, A; Oprisiu, R; Ghitu, S; Said, S; Ghazali, A; Moriniere, P; El Esper, N; Solal, MEC; Brazier, M; Bouillon, R; Pruna, A
    Adynamic bone disease in patients on maintenance dialysis: clinical relevance, non-invasive diagnosis and preventive treatment
    NIEREN-UND HOCHDRUCKKRANKHEITEN
    
    A. Fournier et al., "Adynamic bone disease in patients on maintenance dialysis: clinical relevance, non-invasive diagnosis and preventive treatment", NIEREN HOCH, 28(10), 1999, pp. 394-401
28. Navarro, JF; Mora, C; Jimenez, A; Torres, A; Macia, M; Garcia, J
    Relationship between serum magnesium and parathyroid hormone levels in hemodialysis patients
    AMERICAN JOURNAL OF KIDNEY DISEASES
    
    J.F. Navarro et al., "Relationship between serum magnesium and parathyroid hormone levels in hemodialysis patients", AM J KIDNEY, 34(1), 1999, pp. 43-48
29. Couttenye, MM; D'Haese, PC; Verschoren, WJ; Behets, GJ; Schrooten, I; De Broe, ME
    Low bone turnover in patients with renal failure
    KIDNEY INTERNATIONAL
    
    M.M. Couttenye et al., "Low bone turnover in patients with renal failure", KIDNEY INT, 56, 1999, pp. S70-S76
30. Ritz, E; Schomig, M; Bommer, J
    Osteodystrophy in the millennium
    KIDNEY INTERNATIONAL
    
    E. Ritz et al., "Osteodystrophy in the millennium", KIDNEY INT, 56, 1999, pp. S94-S98
31. Monier-Faugere, MC; Geng, ZP; Friedler, RM; Qi, QL; Kubodera, N; Slatopolsky, E; Malluche, HH
    22-Oxacalcitriol suppresses secondary hyperparathyroidism without inducinglow bone turnover in dogs with renal failure
    KIDNEY INTERNATIONAL
    
    M.C. Monier-Faugere et al., "22-Oxacalcitriol suppresses secondary hyperparathyroidism without inducinglow bone turnover in dogs with renal failure", KIDNEY INT, 55(3), 1999, pp. 821-832
32. McIntyre, CW; Schroeder, NJ; Burrin, JM; Cunningham, J
    Effects of new analogues of vitamin D on bone cells: Implications for treatment of uremic bone disease
    KIDNEY INTERNATIONAL
    
    C.W. McIntyre et al., "Effects of new analogues of vitamin D on bone cells: Implications for treatment of uremic bone disease", KIDNEY INT, 55(2), 1999, pp. 500-511
33. Sanchez, CP; Goodman, WG; Salusky, IB
    Prevention of renal osteodystrophy in predialysis patients
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES
    
    C.P. Sanchez et al., "Prevention of renal osteodystrophy in predialysis patients", AM J MED SC, 317(6), 1999, pp. 398-404
34. HEAF JG; LOKKEGARD H
    PARATHYROID-HORMONE DURING MAINTENANCE DIALYSIS - INFLUENCE OF LOW-CALCIUM DIALYSATE, PLASMA-ALBUMIN AND AGE
    JN. Journal of nephrology
    
    J.G. Heaf e H. Lokkegard, "PARATHYROID-HORMONE DURING MAINTENANCE DIALYSIS - INFLUENCE OF LOW-CALCIUM DIALYSATE, PLASMA-ALBUMIN AND AGE", JN. Journal of nephrology, 11(4), 1998, pp. 203-210
35. COEN G; BALLANTI P; BONUCCI E; CALABRIA S; CENTORRINO M; FASSINO V; MANNI M; MANTELLA D; MAZZAFERRO S; NAPOLETANO I; SARDELLA D; TAGGI F
    BONE MARKERS IN THE DIAGNOSIS OF LOW TURNOVER OSTEODYSTROPHY IN HEMODIALYSIS-PATIENTS
    Nephrology, dialysis, transplantation
    
    G. Coen et al., "BONE MARKERS IN THE DIAGNOSIS OF LOW TURNOVER OSTEODYSTROPHY IN HEMODIALYSIS-PATIENTS", Nephrology, dialysis, transplantation, 13(9), 1998, pp. 2294-2302
36. CARVALHO AB; LOBAO RRS; CUPPARI L; DRAIBE SA; AJZEN H
    DOES HYPOPHOSPHATEMIA INDUCE HYPOPARATHYROIDISM IN PREDIALYSIS PATIENTS
    Nephrology, dialysis, transplantation
    
    A.B. Carvalho et al., "DOES HYPOPHOSPHATEMIA INDUCE HYPOPARATHYROIDISM IN PREDIALYSIS PATIENTS", Nephrology, dialysis, transplantation, 13, 1998, pp. 12-14
37. OLAIZOLA I; AZNAREZ A; JORGETTI V; PETRAGLIA A; CAORSI H; ACUNA G; FAJARDO L; AMBROSONI P; MAZZUCHI N
    ARE THERE ANY DIFFERENCES IN THE PARATHYROID RESPONSE IN THE DIFFERENT TYPES OF RENAL OSTEODYSTROPHY
    Nephrology, dialysis, transplantation
    
    I. Olaizola et al., "ARE THERE ANY DIFFERENCES IN THE PARATHYROID RESPONSE IN THE DIFFERENT TYPES OF RENAL OSTEODYSTROPHY", Nephrology, dialysis, transplantation, 13, 1998, pp. 15-18
38. CARLINI RG; ROJAS E; ARMINIO A; WEISINGER JR; BELLORINFONT E
    WHAT ARE THE BONE-LESIONS IN PATIENTS WITH MORE THAN 4 YEARS OF A FUNCTIONING RENAL-TRANSPLANT
    Nephrology, dialysis, transplantation
    
    R.G. Carlini et al., "WHAT ARE THE BONE-LESIONS IN PATIENTS WITH MORE THAN 4 YEARS OF A FUNCTIONING RENAL-TRANSPLANT", Nephrology, dialysis, transplantation, 13, 1998, pp. 103-104
39. EICHHORN M
    CLINIC AND THERAPY OF THE RENAL OSTEOPATHY - OSTEOPATHY IN KIDNEY PATIENTS
    Nieren- und Hochdruckkrankheiten
    
    M. Eichhorn, "CLINIC AND THERAPY OF THE RENAL OSTEOPATHY - OSTEOPATHY IN KIDNEY PATIENTS", Nieren- und Hochdruckkrankheiten, 27(6), 1998, pp. 270-273
40. HUMPFNER A
    ALUMINUM-RELATED OSTEODYSTROPHY - YESTERDAY AND TODAY
    Nieren- und Hochdruckkrankheiten
    
    A. Humpfner, "ALUMINUM-RELATED OSTEODYSTROPHY - YESTERDAY AND TODAY", Nieren- und Hochdruckkrankheiten, 27(6), 1998, pp. 274-281
41. Werthmann, G; Schulz, W
    Interpretation and clinical significance of bone alkaline phosphatase discriminating adynamic bone disease and high turnover in dialysis patients
    NIEREN-UND HOCHDRUCKKRANKHEITEN
    
    G. Werthmann e W. Schulz, "Interpretation and clinical significance of bone alkaline phosphatase discriminating adynamic bone disease and high turnover in dialysis patients", NIEREN HOCH, 27(10), 1998, pp. 443-450
42. FOURNIER A; OPRISIU R; HOTTELART C; YVERNEAU PH; GHAZALI A; ATIK A; HEDRI H; SAID S; SECHET A; RASOLOMBOLOLONA M; ABIGHANEM O; SARRAJ A; ELESPER N; MORINIERE P; BOUDAILLIEZ B; WESTEEL PF; ACHARD JM; PRUNA A
    RENAL OSTEODYSTROPHY IN DIALYSIS PATIENTS - DIAGNOSIS AND TREATMENT
    Artificial organs
    
    A. Fournier et al., "RENAL OSTEODYSTROPHY IN DIALYSIS PATIENTS - DIAGNOSIS AND TREATMENT", Artificial organs, 22(7), 1998, pp. 530-557
43. WEINREICH T
    PREVENTION OF RENAL OSTEODYSTROPHY IN PERITONEAL-DIALYSIS
    Kidney international
    
    T. Weinreich, "PREVENTION OF RENAL OSTEODYSTROPHY IN PERITONEAL-DIALYSIS", Kidney international, 54(6), 1998, pp. 2226-2233
44. CANNATAANDIA JB
    HYPOKINETIC AZOTEMIC OSTEODYSTROPHY
    Kidney international
    
    J.B. Cannataandia, "HYPOKINETIC AZOTEMIC OSTEODYSTROPHY", Kidney international, 54(3), 1998, pp. 1000-1016
45. SCHROOTEN I; CABRERA W; GOODMAN WG; DAUWE S; LAMBERTS LV; MARYNISSEN R; DORRINE W; DEBROE ME; DHAESE PC
    STRONTIUM CAUSES OSTEOMALACIA IN CHRONIC-RENAL-FAILURE RATS
    Kidney international
    
    I. Schrooten et al., "STRONTIUM CAUSES OSTEOMALACIA IN CHRONIC-RENAL-FAILURE RATS", Kidney international, 54(2), 1998, pp. 448-456
46. BARDIN T
    RENAL OSTEODYSTROPHY
    Revue du rhumatisme
    
    T. Bardin, "RENAL OSTEODYSTROPHY", Revue du rhumatisme, 64(6), 1997, pp. 114-118
47. MAZZAFERRO S; PERRUZZA I; COSTANTINI S; PASQUALI M; ONORATO L; SARDELLA D; GIORDANO R; CIARALLI L; BALLANTI P; BONUCCI E; CINOTTI GA; COEN G
    RELATIVE ROLES OF INTESTINAL-ABSORPTION AND DIALYSIS-FLUID-RELATED EXPOSURE IN THE ACCUMULATION OF ALUMINUM IN HEMODIALYSIS-PATIENTS
    Nephrology, dialysis, transplantation
    
    S. Mazzaferro et al., "RELATIVE ROLES OF INTESTINAL-ABSORPTION AND DIALYSIS-FLUID-RELATED EXPOSURE IN THE ACCUMULATION OF ALUMINUM IN HEMODIALYSIS-PATIENTS", Nephrology, dialysis, transplantation, 12(12), 1997, pp. 2679-2682
48. COUTTENYE MM; DHAESE PC; DENG JT; VANHOOF VO; VERPOOTEN GA; DEBROE ME
    HIGH PREVALENCE OF ADYNAMIC BONE-DISEASE DIAGNOSED BY BIOCHEMICAL MARKERS IN A WIDE SAMPLE OF THE EUROPEAN CAPD POPULATION
    Nephrology, dialysis, transplantation
    
    M.M. Couttenye et al., "HIGH PREVALENCE OF ADYNAMIC BONE-DISEASE DIAGNOSED BY BIOCHEMICAL MARKERS IN A WIDE SAMPLE OF THE EUROPEAN CAPD POPULATION", Nephrology, dialysis, transplantation, 12(10), 1997, pp. 2144-2150
49. MONTENEGRO J; SARACHO R; GONZALEZ O; MOINA I; MARTINEZ I
    REVERSIBILITY OF PARATHYROID-GLAND SUPPRESSION IN CAPD PATIENTS WITH LOW I-PTH LEVELS
    Clinical nephrology
    
    J. Montenegro et al., "REVERSIBILITY OF PARATHYROID-GLAND SUPPRESSION IN CAPD PATIENTS WITH LOW I-PTH LEVELS", Clinical nephrology, 48(6), 1997, pp. 359-363
50. NAVARRO JF; MACIA ML; GALLEGO E; MENDEZ ML; CHAHIN J; GARCIANIETO V; GARCIA JJ
    SERUM MAGNESIUM CONCENTRATION AND PTH LEVELS - IS LONG-TERM CHRONIC HYPERMAGNESEMIA A RISK FACTOR FOR ADYNAMIC BONE-DISEASE
    Scandinavian journal of urology and nephrology
    
    J.F. Navarro et al., "SERUM MAGNESIUM CONCENTRATION AND PTH LEVELS - IS LONG-TERM CHRONIC HYPERMAGNESEMIA A RISK FACTOR FOR ADYNAMIC BONE-DISEASE", Scandinavian journal of urology and nephrology, 31(3), 1997, pp. 275-280
51. COUTTENYE MM; DHAESE PC; VANHOOF VO; LEMONIATOU E; GOODMAN W; VERPOOTEN GA; DEBROE ME
    LOW SERUM LEVELS OF ALKALINE-PHOSPHATASE OF BONE ORIGIN - A GOOD MARKER OF ADYNAMIC BONE-DISEASE IN HEMODIALYSIS-PATIENTS
    Nephrology, dialysis, transplantation
    
    M.M. Couttenye et al., "LOW SERUM LEVELS OF ALKALINE-PHOSPHATASE OF BONE ORIGIN - A GOOD MARKER OF ADYNAMIC BONE-DISEASE IN HEMODIALYSIS-PATIENTS", Nephrology, dialysis, transplantation, 11(6), 1996, pp. 1065-1072
52. COEN G; MAZZAFERRO S; BALLANTI P; SARDELLA D; CHICCA S; MANNI M; BONUCCI E
    RENAL BONE-DISEASE IN 76 PATIENTS WITH VARYING DEGREES OF PREDIALYSISCHRONIC-RENAL-FAILURE - A CROSS-SECTIONAL STUDY
    Nephrology, dialysis, transplantation
    
    G. Coen et al., "RENAL BONE-DISEASE IN 76 PATIENTS WITH VARYING DEGREES OF PREDIALYSISCHRONIC-RENAL-FAILURE - A CROSS-SECTIONAL STUDY", Nephrology, dialysis, transplantation, 11(5), 1996, pp. 813-819
53. BALLANTI P; WEDARD BM; BONUCCI E
    FREQUENCY OF ADYNAMIC BONE-DISEASE AND ALUMINUM STORAGE IN ITALIAN UREMIC PATIENTS - RETROSPECTIVE ANALYSIS OF 1429 ILIAC CREST BIOPSIES
    Nephrology, dialysis, transplantation
    
    P. Ballanti et al., "FREQUENCY OF ADYNAMIC BONE-DISEASE AND ALUMINUM STORAGE IN ITALIAN UREMIC PATIENTS - RETROSPECTIVE ANALYSIS OF 1429 ILIAC CREST BIOPSIES", Nephrology, dialysis, transplantation, 11(4), 1996, pp. 663-667
54. SCHMIDTGAYK H; DRUEKE T; RITZ E
    NONINVASIVE CIRCULATING INDICATORS OF BONE METABOLISM IN UREMIC PATIENTS - CAN THEY REPLACE BONE-BIOPSY
    Nephrology, dialysis, transplantation
    
    H. Schmidtgayk et al., "NONINVASIVE CIRCULATING INDICATORS OF BONE METABOLISM IN UREMIC PATIENTS - CAN THEY REPLACE BONE-BIOPSY", Nephrology, dialysis, transplantation, 11(3), 1996, pp. 415-418
55. MONIERFAUGERE MC; MALLUCHE HH
    TRENDS IN RENAL OSTEODYSTROPHY - A SURVEY FROM 1983 TO 1995 IN A TOTAL OF 2248 PATIENTS
    Nephrology, dialysis, transplantation
    
    M.C. Monierfaugere e H.H. Malluche, "TRENDS IN RENAL OSTEODYSTROPHY - A SURVEY FROM 1983 TO 1995 IN A TOTAL OF 2248 PATIENTS", Nephrology, dialysis, transplantation, 11, 1996, pp. 111-120
56. HUMPFNER A
    ADYNAMIC BONE-DISEASE (ABD) UNDER INFLUEN CE OF ALUMINUM IN CHRONIC-RENAL-FAILURE AND DIALYSIS (HD, CAPD) - RISK OF UNDERESTIMATED SUBCLINICAL AL-TOXICITY IN CASES WITH DECREASED THRESHOLD FOR AL-TOXICITY NOWADAYS
    Nieren- und Hochdruckkrankheiten
    
    A. Humpfner, "ADYNAMIC BONE-DISEASE (ABD) UNDER INFLUEN CE OF ALUMINUM IN CHRONIC-RENAL-FAILURE AND DIALYSIS (HD, CAPD) - RISK OF UNDERESTIMATED SUBCLINICAL AL-TOXICITY IN CASES WITH DECREASED THRESHOLD FOR AL-TOXICITY NOWADAYS", Nieren- und Hochdruckkrankheiten, 25(2), 1996, pp. 50-71
57. COEN G; MANNI M; ADDARI O; BALLANTI P; PASQUALI M; CHICCA S; MAZZAFERRO S; NAPOLETANO I; SARDELLA D; BONUCCI E
    METABOLIC-ACIDOSIS AND OSTEODYSTROPHIC BONE-DISEASE IN PREDIALYSIS CHRONIC-RENAL-FAILURE - EFFECT OF CALCITRIOL TREATMENT
    Mineral and electrolyte metabolism
    
    G. Coen et al., "METABOLIC-ACIDOSIS AND OSTEODYSTROPHIC BONE-DISEASE IN PREDIALYSIS CHRONIC-RENAL-FAILURE - EFFECT OF CALCITRIOL TREATMENT", Mineral and electrolyte metabolism, 21(6), 1995, pp. 375-382
58. FOURNIER A; MORINIERE P; OPRISIU R; MARIE A; YVERNEAU HP; SAID S; ELDIN HM; ELESPER N
    BIOCHEMICAL-DIAGNOSIS AND PREVENTION OF A DYNAMIC BONE-DISEASE
    Nieren- und Hochdruckkrankheiten
    
    A. Fournier et al., "BIOCHEMICAL-DIAGNOSIS AND PREVENTION OF A DYNAMIC BONE-DISEASE", Nieren- und Hochdruckkrankheiten, 24(8), 1995, pp. 373-379
59. COUTTENYE MM; DEBROE ME
    LOW BONE ALKALINE-PHOSPHATASE - A SENSITI VE, SPECIFIC MARKER FOR ADYNAMIC BONE-DISEASE IN DIALYSIS PATIENTS
    Nieren- und Hochdruckkrankheiten
    
    M.M. Couttenye e M.E. Debroe, "LOW BONE ALKALINE-PHOSPHATASE - A SENSITI VE, SPECIFIC MARKER FOR ADYNAMIC BONE-DISEASE IN DIALYSIS PATIENTS", Nieren- und Hochdruckkrankheiten, 24(8), 1995, pp. 380-383